Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypoten
This prospective, randomized controlled trial investigates the effect of four different anesthetic maintenance techniques on surgical field conditions, hemodynamic stability, and neuroprotection during functional endoscopic sinus surgery (FESS) performed under controlled hypotension. Patients are randomly assigned to r
| Condition(s) | Magnesium Sulfate, Remifentanil, S 100beta, S100 Beta Protein, Human, Neuron-Specific Enolase, Brain Ischemia, Sevoflurane Anaesthesia, Propofol/Remifentanil, Ketamine |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This prospective, randomized controlled trial investigates the effect of four different anesthetic maintenance techniques on surgical field conditions, hemodynamic stability, and neuroprotection during functional endoscopic sinus surgery (FESS) performed under controlled hypotension. Patients are randomly assigned to receive either total intravenous anesthesia with propofol-remifentanil, propofol-remifentanil with adjunct ketamine and magnesium, sevoflurane-remifentanil, or sevoflurane-remifentanil with adjunct ketamine and magnesium. Primary outcomes include serum biomarkers of neuronal injury (S100B and neuron-specific enolase, NSE) measured perioperatively, as well as surgical field visibility and intraoperative bleeding scores. Secondary outcomes include recovery profile and postoperat |
| Who can participate | Inclusion Criteria : Adult patients (≥18 years old). Scheduled for F.E.S.S (Functional endoscopic sinus surgery ) under general anesthesia. Able to provide informed consent Exclusion Criteria: Emergency surgery. ASA physical status IV-V. Severe hepatic or renal dysfunction. Known allergy or contraindication to study drugs. Pregnant or lactating women. unable to provide informed consent Patients unwilling or unable to provide consent. |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Lead sponsor | University General Hospital of Patras |
| Locations | Pátrai, Achaia, Greece |
| Start date | 2025-09-11 |
| NCT ID | NCT07181564 |
| Official listing | https://clinicaltrials.gov/study/NCT07181564 |